Medical Device News Magazine

Puzzle Medical Devices Inc. Announces the Closing of a First Financing Round: Funds to Support Clinical Testing of the Transcatheter Pump

Company Provides Update on its Minimally Invasive Transcatheter Heart Pump

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

June 15, 2020

Puzzle Medical Devices Inc., today announces the closure of its first convertible debenture financing round led by Canadian entrepreneur Pascal Labrecque.

Puzzle Medical Devices advises other participants include a United States venture capital firm, entrepreneurs and interventional cardiologists practicing in Canada, the United States and Europe.

This investment follows the successful completion of Puzzle Medical’s first preclinical studies and will support the continued development towards clinical testing of a revolutionary transcatheter pump intended for chronic support.

Puzzle Medical Devices Inc. cites an estimated 26 million patients suffer from heart failure worldwide, resulting in a global healthcare spending of $108B. While great improvements in chronic heart failure therapy have been achieved in the last couple of decades, mortality and readmission rates have seen a limited impact. Patients with advanced heart failure − refractory to medical therapy − are often at increased risk for conventional surgical left ventricular assist device implantation. Even with optimal patient care, cumulating to yearly spending of $28B in the United States, these patients have a 2-year survival rate of 50% and limited quality of life.

“This technology clearly answers an unmet need in the management of chronic heart failure patients,” said Philippe Généreux, MD, Interventional Cardiologist at Morristown Medical Center, New Jersey, USA. “I have been extremely impressed by the success achieved during the initial preclinical work and remain excited and confident about its future application in patients.” Puzzle Medical’s focus is to improve patient quality of life and reduce the global economic burden related to heart failure. Puzzle Medical is developing a proprietary transcatheter heart pump associated with minimal trauma to the blood components, allowing for safe and efficient heart support without open-heart surgery.

“The accomplishments achieved by Puzzle Medical in such a short period of time are remarkable,” stated Pascal Labrecque. “It already has international support from pioneering interventional cardiologists, on top of an ever-growing IP portfolio. We are enthusiastic about its competent team and bright future.”

“This financing clearly demonstrates confidence in our strategic direction and ability to disrupt the interventional cardiology space by developing advanced, innovative technologies,” said Stuart Kozlick, CEO, Puzzle Medical Devices. “We are dedicated to improving every aspect of advanced heart failure with novel hemodynamic support solutions, as recently evidenced by the successful completion of acute preclinical implantations.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”